Based on the previous conclusion that G6PD promoted RCC proliferation through positive feedback regulation of ROS-pSTAT3 axis [19], the present findings led to the hypothesis that ROS regulated G6PD overexpression might not only through pSTAT3 activation but also the NF-κB signaling pathway. This evidence concerns the gene NFKB1 and renal cell carcinoma.